<DOC>
	<DOCNO>NCT02040207</DOCNO>
	<brief_summary>The purpose research study test safety local tolerance repeat treatment AM-101 .</brief_summary>
	<brief_title>AM-101 Treatment Post-Acute Tinnitus 2</brief_title>
	<detailed_description>This open-label extension study assess safety local tolerance repeat treatment AM-101 subject previously treat scope TACTT3 study .</detailed_description>
	<mesh_term>Tinnitus</mesh_term>
	<criteria>Completion TACTT3 study ; Negative pregnancy test ( woman childbearing potential ) ; Willing able attend study visit . Other protocoldefined inclusion criterion may apply . Adverse event lead treatment discontinuation TACTT3 ; Meniere 's Disease , endolymphatic hydrops , acoustic neuroma , severe fluctuate hearing loss , otitis medium , otitis externa , abnormality tympanic membrane ; Ongoing drugbased therapy otitis medium otitis externa ; Drugbased therapy know potentially tinnitusinducing ; Other treatment tinnitus ; Drug abuse alcoholism ; Subjects psychiatric disease require drug treatment ; Use antidepressant antianxiety medication ; Any clinically relevant disorder abnormality physical examination ; Women breastfeeding , pregnant planning become pregnant study ; Women childbearing potential unwilling unable practice contraception . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>76 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>